SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001493152-20-022963
Filing Date
2020-12-04
Accepted
2020-12-04 16:21:21
Documents
13
Period of Report
2020-10-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-ka.htm   iXBRL 8-K/A 40421
2 ex10-1.htm EX-10.1 32583
  Complete submission text file 0001493152-20-022963.txt   261361

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE crbp-20201008.xsd EX-101.SCH 3198
4 XBRL LABEL FILE crbp-20201008_lab.xml EX-101.LAB 35273
5 XBRL PRESENTATION FILE crbp-20201008_pre.xml EX-101.PRE 23154
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-ka_htm.xml XML 4353
Mailing Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001595097 (see all company filings)

IRS No.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-37348 | Film No.: 201370123
SIC: 2834 Pharmaceutical Preparations